EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cucurbitane-Type Glycosides and Sterol from Momordica balsamina Linn. As Target Potential Leads for Diabetes Management

Buang Matseke iD, Daniel Tswaledi, Raymond T Makola iD, Xavier Siwe-Noundou iD, Ali H Rabbad iD, Sekelwa Cosa iD, Kokoette Bassey

Molecules · 08.04.2026 · 31 (8) · 1231

DOI: 10.3390/molecules31081231 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 08.04.2026. Verfasst von Buang Matseke und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, School of Pharmacy, Sefako Makgatho Health Sciences University, Ga-Rankuwa, Pretoria 0204, South Africa. Hauptthemen laut MEDLINE: Momordica, Hypoglycemic Agents, Glycosides, Diabetes Mellitus. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation, Department of Pharmaceutical Sciences, School of Pharmacy, Sefako Makgatho Health Sciences University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Momordica balsamina Linn. is widely used in traditional medicine for the management of diabetes; however, the specific bioactive compounds responsible for this activity have not been fully isolated and structurally elucidated from South African populations. This study reports, for the first time, the isolation and comprehensive characterization of antidiabetic compounds from South African samples of M. balsamina. Crude extracts were obtained through sequential solvent extraction, followed by isolation and purification using vacuum liquid chromatography. Structural elucidation was achieved using HPLC, UPLC–MS, FTIR, and NMR spectroscopy. The antidiabetic potential of the isolated compounds was evaluated through inhibition assays against α-amylase, α-glucosidase, and β-glucosidase. Molecular docking was employed to examine binding interactions with these target enzymes, while cytotoxicity was assessed using the MTT assay against Vero and HEK-293 cell lines. Two compounds, DD26.27 and EAEA1.2, were successfully isolated from dichloromethane and ethyl acetate extracts, respectively. Both compounds demonstrated concentration-dependent inhibition of the tested enzymes. Notably, molecular docking revealed strong binding affinities and favorable interactions with key catalytic residues, surpassing the standard drug acarbose and corroborating the in vitro results. Cytotoxicity studies confirmed that, at lower concentrations, the compounds were non-toxic to the tested cell lines. Collectively, these findings provide novel scientific validation of the traditional use of M. balsamina in South Africa and identify promising lead compounds for further in vivo studies and antidiabetic drug development targeting postprandial hyperglycemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MomordicaHypoglycemic AgentsGlycosidesDiabetes MellitusHumansMolecular Docking SimulationAnimalsPlant ExtractsHEK293 CellsVero CellsChlorocebus aethiopsGlycoside Hydrolase InhibitorsMolecular Structurealpha-GlucosidasesTriterpenes

Stichwörter der Autor:innen

Momordica balsaminacompound isolationcytotoxicitydiabetes mellitusmolecular dockingα-amylaseα-glucosidaseβ-glucosidase

Substanzen

Hypoglycemic AgentsGlycosidesPlant ExtractscucurbitaneGlycoside Hydrolase Inhibitorsalpha-GlucosidasesTriterpenes

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, School of Pharmacy, Sefako Makgatho Health Sciences University, Ga-Rankuwa, Pretoria 0204, South Africa.
  • Department of Biochemistry and Biotechnology, School of Science and Technology, Sefako Makgatho Health Sciences University, Ga-Rankuwa, Pretoria 0204, South Africa.
  • Department of Biochemistry, Microbiology and Biotechnology, University of Limpopo, Sovenga, Polokwane 0727, South Africa.
  • Department of Biochemistry, Genetics and Microbiology, University of Pretoria, Hatfield, Pretoria 0028, South Africa.

ORCID-Profile: Buang Matseke, Raymond T Makola, Xavier Siwe-Noundou, Ali H Rabbad, Sekelwa Cosa

Förderung

  • National Research Foundation
  • Department of Pharmaceutical Sciences, School of Pharmacy, Sefako Makgatho Health Sciences University

Zitieren

APA

Matseke, B., Tswaledi, D., Makola, R. T., Siwe-Noundou, X., Rabbad, A. H., Cosa, S., & Bassey, K. (2026). Cucurbitane-Type Glycosides and Sterol from Momordica balsamina Linn. As Target Potential Leads for Diabetes Management. Molecules, 31(8), 1231. https://doi.org/10.3390/molecules31081231

Vancouver

Matseke B, Tswaledi D, Makola RT, Siwe-Noundou X, Rabbad AH, Cosa S, et al. Cucurbitane-Type Glycosides and Sterol from Momordica balsamina Linn. As Target Potential Leads for Diabetes Management. Molecules. 2026;31(8):1231. doi:10.3390/molecules31081231

BibTeX
@article{Matseke2026,
  author = {Matseke, Buang and Tswaledi, Daniel and Makola, Raymond T and Siwe-Noundou, Xavier and Rabbad, Ali H and Cosa, Sekelwa and Bassey, Kokoette},
  title = {Cucurbitane-Type Glycosides and Sterol from Momordica balsamina Linn. As Target Potential Leads for Diabetes Management},
  journal = {Molecules},
  year = {2026},
  volume = {31},
  number = {8},
  pages = {1231},
  doi = {10.3390/molecules31081231}
}
Kostenlos starten →